Hla Antigens and Bronchogenic Carcinoma in the Greek Population

Authors

  • M. Toumbis Second Department of Chest Medicine, Athens Hospital of Chest Diseases, and the First Department of Medicine, Athens University, Athens, Greece
  • J. Zervas Second Department of Chest Medicine, Athens Hospital of Chest Diseases, and the First Department of Medicine, Athens University, Athens, Greece
  • O. Anagnostopoulou Second Department of Chest Medicine, Athens Hospital of Chest Diseases, and the First Department of Medicine, Athens University, Athens, Greece
  • K. Konstantopoulos Second Department of Chest Medicine, Athens Hospital of Chest Diseases, and the First Department of Medicine, Athens University, Athens, Greece
  • G. Krimbeni Second Department of Chest Medicine, Athens Hospital of Chest Diseases, and the First Department of Medicine, Athens University, Athens, Greece
  • V. Kotsovoulou Second Department of Chest Medicine, Athens Hospital of Chest Diseases, and the First Department of Medicine, Athens University, Athens, Greece
  • F. Fessas Second Department of Chest Medicine, Athens Hospital of Chest Diseases, and the First Department of Medicine, Athens University, Athens, Greece

DOI:

https://doi.org/10.3109/02841869109092420

Keywords:

HLA-antigens, bronchogenic carcinoma

Abstract

the distribution of HLA antigens was studied in 85 Greek patients with bronchogenic carcinoma. Fifty-seven specific HLA antisera were used to determine 27 HLA-A and B antigens, with the two-stage standard NIH microlymphocytotoxicity assay. the results were compared with those in a control group, consisting of 400 healthy individuals. in the whole group of patients there was a significantly higher frequency of HLA-AW19 and HLA-A29 (p< 0.003 and p < 0.006 respectively) and a lower frequency of HLA-A2 and HLA-A3 (p< 0.014 and p< 0.006 respectively) than in the control population. in patients with squamous cell carcinoma there was a significantly higher frequency of HLA-AW19 and lower frequency of HLA-A2 (p<0.02 and p < 0.05 respectively). in small cell carcinoma patients there was a significantly lower frequency of HLA-A3 (p<0.04) than among the controls. in patients with adenocarcinoma no significant change of HLA antigen frequencies was observed when compared to the controls.

Downloads

Download data is not yet available.

Downloads

Published

1991-01-01

How to Cite

Toumbis, M., Zervas, J., Anagnostopoulou, O., Konstantopoulos, K., Krimbeni, G., Kotsovoulou, V., & Fessas, F. (1991). Hla Antigens and Bronchogenic Carcinoma in the Greek Population. Acta Oncologica, 30(5), 575–578. https://doi.org/10.3109/02841869109092420